Michael Manns

4.3k total citations
51 papers, 1.6k citations indexed

About

Michael Manns is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Michael Manns has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 25 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Michael Manns's work include Liver Disease Diagnosis and Treatment (18 papers), Liver Diseases and Immunity (17 papers) and Hepatitis C virus research (13 papers). Michael Manns is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Liver Diseases and Immunity (17 papers) and Hepatitis C virus research (13 papers). Michael Manns collaborates with scholars based in Germany, United States and United Kingdom. Michael Manns's co-authors include Karl‐Hermann Meyer zum Büschenfelde, Christian P. Strassburg, K. H. Meyer zum Büschenfelde, Ansgar W. Lohse, Guido Gerken, Thomas Poralla, T. Poralla, Hans‐Peter Dienes, Zum Büschenfelde and H Löhr and has published in prestigious journals such as Hepatology, Analytical Biochemistry and Gut.

In The Last Decade

Michael Manns

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Manns Germany 25 1.1k 858 314 222 175 51 1.6k
I G McFarlane United Kingdom 22 937 0.9× 793 0.9× 180 0.6× 239 1.1× 126 0.7× 43 1.4k
Pascal Lapierre Canada 24 1.0k 0.9× 856 1.0× 240 0.8× 239 1.1× 325 1.9× 47 1.8k
F Paronetto United States 21 565 0.5× 609 0.7× 252 0.8× 160 0.7× 283 1.6× 71 1.8k
Michel Doffoël France 23 1.4k 1.3× 1.1k 1.3× 300 1.0× 107 0.5× 129 0.7× 70 1.9k
Ludger Leifeld Germany 26 824 0.8× 810 0.9× 477 1.5× 143 0.6× 227 1.3× 73 2.1k
Kenichi Morikawa Japan 24 1.2k 1.1× 996 1.2× 211 0.7× 138 0.6× 295 1.7× 76 1.8k
Kentaro Yoshioka Japan 27 1.7k 1.6× 1.7k 2.0× 116 0.4× 204 0.9× 159 0.9× 89 2.3k
George N. Dalekos Greece 23 2.0k 1.8× 1.8k 2.1× 709 2.3× 526 2.4× 153 0.9× 43 2.5k
Stefan Lüth Germany 20 552 0.5× 599 0.7× 337 1.1× 108 0.5× 267 1.5× 75 1.4k
Antônio Atílio Laudanna Brazil 23 460 0.4× 544 0.6× 574 1.8× 128 0.6× 107 0.6× 74 1.4k

Countries citing papers authored by Michael Manns

Since Specialization
Citations

This map shows the geographic impact of Michael Manns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Manns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Manns more than expected).

Fields of papers citing papers by Michael Manns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Manns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Manns. The network helps show where Michael Manns may publish in the future.

Co-authorship network of co-authors of Michael Manns

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Manns. A scholar is included among the top collaborators of Michael Manns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Manns. Michael Manns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pischke, Sven, Andrej Potthoff, Bärbel Hauröder, et al.. (2010). Hepatitis E: Eine Infektionskrankheit erlebt einen Bedeutungswechsel. DMW - Deutsche Medizinische Wochenschrift. 135(22). 1129–1133. 12 indexed citations
2.
Strassburg, Christian P. & Michael Manns. (2009). Treatment of Autoimmune Hepatitis. Seminars in Liver Disease. 29(3). 273–285. 27 indexed citations
3.
Manns, Michael & Diego Vergani. (2009). Autoimmune Hepatitis. Seminars in Liver Disease. 29(3). 239–240. 12 indexed citations
4.
Cornberg, Markus, Ulrike Protzer, Matthias Dollinger, et al.. (2007). Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-(HBV-)Infektion: „Upgrade” der Leitlinie, AWMF-Register-Nr.: 021/011. Zeitschrift für Gastroenterologie. 45(6). 525–574. 29 indexed citations
5.
Nüssler, Andreas K., Sarah König, Michael Ott, et al.. (2006). Present status and perspectives of cell-based therapies for liver diseases. Journal of Hepatology. 45(1). 144–159. 151 indexed citations
6.
Strassburg, Christian P. & Michael Manns. (2006). Approaches to Liver Biopsy Techniques-Revisited. Seminars in Liver Disease. 26(4). 318–327. 53 indexed citations
8.
Benter, T., et al.. (1995). Optimization and Reproducibility of Random Amplified Polymorphic DNA in Human. Analytical Biochemistry. 230(1). 92–100. 30 indexed citations
9.
Straub, P., et al.. (1995). Molecular Basis of Drug-Induced Immunological Liver Injury. Seminars in Liver Disease. 15(3). 283–300. 24 indexed citations
10.
Ramadori, Giuliano, Michael Manns, H. Rieder, et al.. (1991). Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. European Journal of Clinical Investigation. 21(3). 323–330. 54 indexed citations
11.
Manns, Michael. (1991). Cytoplasmic Autoantigens in Autoimmune Hepatitis: Molecular Analysis and Clinical Relevance. Seminars in Liver Disease. 11(3). 205–214. 38 indexed citations
12.
Wachter, B. De, Apostolos Kyriatsoulis, Ansgar W. Lohse, et al.. (1990). Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. Journal of Hepatology. 11(2). 232–239. 57 indexed citations
13.
Lohse, Ansgar W., et al.. (1990). Experimental Autoimmune Hepatitis: Disease Induction, Time Course and T–Cell Reactivity. Hepatology. 11(1). 24–30. 106 indexed citations
14.
Press, A. G., et al.. (1990). Antibodies to cytoskeletal proteins in patients with Crohn's disease. European Journal of Clinical Investigation. 20(5). 516–524. 17 indexed citations
15.
Poralla, Thomas, et al.. (1990). Autoantibodies to Human Asialoglycoprotein Receptor in Autoimmune–Type Chronic Hepatitis. Hepatology. 11(4). 606–612. 91 indexed citations
16.
Mayet, W.-J., E Hermann, Michael Bachmann, Michael Manns, & K. H. Meyer zum Büschenfelde. (1990). Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease. Journal of Molecular Medicine. 68(13). 685–691. 5 indexed citations
17.
Meuer, Stefan, Ulrich Moebius, Michael Manns, et al.. (1988). Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. European Journal of Immunology. 18(9). 1447–1452. 60 indexed citations
18.
Kyriatsoulis, Apostolos, Michael Manns, Guido Gerken, et al.. (1988). Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis. Journal of Hepatology. 6(3). 283–290. 17 indexed citations
19.
Heß, Georg, Christian Weber, J. Knolle, et al.. (1987). Detection of Hepatitis B Virus Markers in Sera of Asymptomatic Hepatitis B Surface Antigen Carriers with Special Emphasis to Pre-S-Encoded Proteins. Digestion. 38(2). 90–95. 2 indexed citations
20.
Manns, Michael, Guido Gerken, Apostolos Kyriatsoulis, et al.. (1987). Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: Identification and characterization by radioimmunoassay and immunoblotting†. Hepatology. 7(5). 893–899. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026